HTG Molecular Diagnostics Up Nearly 400% In 2 Days

HTG Molecular Diagnostics Inc HTGM shares are trading higher by $6.60 at $10.53 in Friday's session. That comes on top of Thursday's gain of nearly $2.00 as it rallied from $2.14 to $3.93 on monster volume.

After Wednesday's close, the company (a maker of instruments, reagents and services for molecular profiling applications) announced it had obtained CE marking for in the European Union for its HTG EdgeSeq ALKPlus Assay. The diagnostic assay analyzes gene arrangements in patients with lung cancer.

After Thursday's close, HTG reported a Q4 loss of $0.76 per share on revenue of $1.5 million.

After a much higher open, the stock had a brief retreat to $5.97 before continuing its move higher. So far, the ensuing rally taken the issue to $12.45, but has backed off to the $11.00 area. That marks the highest level for the issue since September 2015, when it peaked at $13.10.